Design Therapeutics (DSGN) Cash from Financing Activities (2020 - 2026)
Design Therapeutics (DSGN) recorded Cash from Financing Activities of $605,000 in Q2 2026, up 67.6% from $361,000 a year earlier but down 97.0% from the prior quarter.
Powered by 
Analysis
Design Therapeutics (DSGN) Cash from Financing Activities (2020 - 2026) Analysis & Trends
On a TTM basis, Design Therapeutics' Cash from Financing Activities came in at $45.89 million as of Jun 30, 2026; for FY2025, it came in at $25.74 million.
- Annual Cash from Financing Activities has a five-year compound annual growth rate of -10.4% (FY2020 to FY2025).
- Across earlier years, Cash from Financing Activities came in at $513,000 in FY2024 (-29.1%), $724,000 in FY2023 (+208.1%), $235,000 in FY2022 (-99.9%) and $379.21 million in FY2021 (+751.5%).
- Quarterly Cash from Financing Activities has ranged from -$202,000 in Q2 2022 to $25.32 million in Q4 2025 over the past five years.
- On a year-over-year basis, Cash from Financing Activities rose in three of the last five quarters, with growth averaging 0.1%.
- Peak year-over-year performance for Cash from Financing Activities in the last five years was growth of 403.3% in Q3 2022, against a decline of 100.0% in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $19.93 million (Q1 2026), $25.32 million (Q4 2025) and $37,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Design Therapeutics | 786.63 Mn | -69.40 Mn | - | 605,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 605,000.00 |
| Mar 31, 2026 | 19.93 Mn |
| Dec 31, 2025 | 25.32 Mn |
| Sep 30, 2025 | 37,000.00 |
| Jun 30, 2025 | 361,000.00 |
| Mar 31, 2025 | 23,000.00 |
| Dec 31, 2024 | 263,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 229,000.00 |
| Mar 31, 2024 | 20,000.00 |
| Dec 31, 2023 | 501,000.00 |
| Sep 30, 2023 | 13,000.00 |
| Dec 31, 2022 | 130,000.00 |
| Sep 30, 2022 | 151,000.00 |
| Jun 30, 2022 | -202,000.00 |
| Mar 31, 2022 | 156,000.00 |
| Dec 31, 2021 | 193,000.00 |
| Sep 30, 2021 | 30,000.00 |
| Jun 30, 2021 | 5,000.00 |
| Mar 31, 2021 | 378.98 Mn |
API Access
Design Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=DSGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "DSGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=DSGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();